The Molecular Basis of 5alpha-Reductase Type 2 Deficiency.
Batista RL, Mendonca BB.
Sex Dev. 2022;16(2-3):171-183. doi: 10.1159/000525119. Epub 2022 Jul 6.
PMID:35793650
Longitudinal clinical course in patients with 5alpha-reductase type 2 deficiency treated with testosterone and dihydrotestosterone during infancy and puberty.
Ariyasu D, Nagamatsu F, Aso K, Akiba K, Hasegawa Y.
Endocr J. 2023 Jan 30;70(1):59-67. doi: 10.1507/endocrj.EJ22-0112. Epub 2022 Oct 8.
PMID:36216557
Genetic Analysis of 25 Patients with 5alpha-Reductase Deficiency in Chinese Population.
Han B, Cheng T, Zhu H, Yu J, Zhu WJ, Song HD, Yao H, Qiao J.
Biomed Res Int. 2020 Jun 9;2020:1789514. doi: 10.1155/2020/1789514. eCollection 2020.
PMID:32596280
Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency.
Imperato-McGinley J, Zhu YS.
Mol Cell Endocrinol. 2002 Dec 30;198(1-2):51-9. doi: 10.1016/s0303-7207(02)00368-4.
PMID:12573814
5alpha-reductase activity of genital and nongenital skin fibroblasts from patients with 5alpha-reductase deficiency, androgen insensitivity, or unknown forms of male pseudohermaphroditism.
Pinsky L, Kaufman M, Straisfeld C, Zilahi B, Hall CS.
Am J Med Genet. 1978;1(4):407-16. doi: 10.1002/ajmg.1320010404.